You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
This prospective, multicenter randomized study was designed to evaluate the safety and effectiveness of the Medtronic cryoablation system as an initial first-line rhythm control treatment in patients with symptomatic paroxysmal atrial fibrillation (PAF).
View resultsThis prospective, multicenter, single-arm clinical trial assessed the safety and efficacy of PVI with the Medtronic cryoballoon for treating drug refractory, symptomatic, persistent AF.
Explore the resultsThese two pivotal trials assessed the safety and effectiveness of the Arctic Front and Arctic Front Advance™ cardiac cryoablation catheters.
Learn moreOutcomes
Clinical trials
View the results of multiple clinical trials highlighting the unique benefits of cryo energy.
See resultsThis multicenter, randomized trial compared the efficacy and safety of PVI using cryoablation versus radiofrequency (RFC) ablation.
Read more